SEC Info - Sarepta Therapeutics, Inc. - ‘8-K’ for 6/2/22

SEC Info℠

Home

Help

Please Sign In

Sarepta Therapeutics, Inc. – ‘8-K’ for 6/2/22 – ‘EX-101.SCH’

On: Friday, 6/3/22, at 4:20pm ET · For: 6/2/22 · Accession #: 950170-22-11164 · File #: 1-14895

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/03/22  Sarepta Therapeutics, Inc.        8-K:5,9     6/02/22   11:250K                                   Donnelley … Solutions/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     49K 
 2: EX-10.1     Material Contract                                   HTML     11K 
 6: R1          Document And Entity Information                     HTML     46K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- srpt-20220602_htm                   XML     15K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 5: EX-101.LAB  XBRL Labels -- srpt-20220602_lab                     XML     40K 
 4: EX-101.PRE  XBRL Presentations -- srpt-20220602_pre              XML     31K 
 3: EX-101.SCH  XBRL Schema -- srpt-20220602                         XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-011164-xbrl      Zip     13K

‘EX-101.SCH’ — XBRL Schema — srpt-20220602

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema targetNamespace="http://www.sarepta.com/20220602" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srpt="http://www.sarepta.com/20220602" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>

<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="srpt-20220602_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="srpt-20220602_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>

<link:roleType roleURI="http://www.sarepta.com/20220602/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">

<link:definition> 100000 - Document - Document And Entity Information </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

</xsd:appinfo>

</xsd:annotation>

</xsd:schema>

9 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 3/28/24  Sarepta Therapeutics, Inc.        S-8 POS     3/28/24    4:220K                                   Donnelley … Solutions/FA
 2/28/24  Sarepta Therapeutics, Inc.        10-K       12/31/23  119:18M                                    Donnelley … Solutions/FA
 8/02/23  Sarepta Therapeutics, Inc.        S-8         8/02/23    4:69K                                    Donnelley … Solutions/FA
 2/28/23  Sarepta Therapeutics, Inc.        10-K       12/31/22  119:23M                                    Donnelley … Solutions/FA
 8/02/22  Sarepta Therapeutics, Inc.        S-8         8/02/22    4:58K                                    Donnelley … Solutions/FA
 8/02/22  Sarepta Therapeutics, Inc.        10-Q        6/30/22   79:11M                                    Donnelley … Solutions/FA

↑Top